[Prevention of hemolytic disease in newborn infants using anti-D immunoglobulin G].

Zentralbl Gynakol

Frauengesundheitsschutzdienst des Medizinischen Zentrums in Sibenik.

Published: July 1989

The authors have analyzed the prevention of Rh-immunization from 1972 to 1983. Results are presented in two six-year periods, i.e. from 1972 to 1977 and from 1978 to 1983. Prevention was applied to all rh-negative women, who have been delivered from a rh-negative baby in their first childbirth (with negative sensibilization tests). Anti D IgG was also applied to all women after their second, third, fourth or subsequent delivery, if they were willing to have more children. Women with Du variant of the Rh factor and having a Rh-positive child were also protected. Preparations containing 250 to 300 micrograms of IgG anti-D were used. During the first period we found rh-negative mothers in 18.41 per cent, in 63.48 per cent of them the newborn was Rh-positive. During the second period 17.89 per cent of our women were rh-negative with 58.45 per cent Rh-positive babies. During the first period, protection was afforded to 60.26 per cent of the rh-negative women with incompatible babies, and in the second period to 79.11 per cent, respectively (P less than 0.05). During the second period, 99.70 per cent of women were protected after their first delivery (except of one case with immunization already during pregnancy), in contrast to the first period, where this percentage amounted only to 84.66 per cent (P less than 0.05). During both periods, a total of 69.51 per cent of the rh-negative women having Rh-positive babies received anti-D-immunization.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

rh-negative women
12
second period
12
cent
9
cent women
8
rh-positive babies
8
cent rh-negative
8
cent 005
8
women
7
rh-negative
6
period
6

Similar Publications

Background: This study aimed to explore variations in prenatal care, delivery methods, influencing factors, and neonatal outcomes among Rh-negative pregnant women, so as to improve pregnancy healthcare for this demographic, raise the quality of maternal-fetal management, and safeguard the health of both mother and infant.

Methods: This study included 200 women who received routine prenatal care, exhibited no other pregnancy complications, and were admitted for delivery. They were divided into an observation group (100 Rh-negative blood type) and a control group (100 Rh-positive blood type).

View Article and Find Full Text PDF
Article Synopsis
  • Neonatal jaundice is more prevalent and complex in low and middle-income countries, with limited data on its prevalence in Ethiopia.
  • A study conducted in Bahir Dar city found that 38.8% of the 340 neonates admitted to the neonatal intensive care unit had jaundice.
  • Key factors contributing to neonatal jaundice included being male, prematurity, maternal blood type (especially Rh negative or AB), and ABO incompatibility, indicating a need for improved antenatal blood testing and accessible treatment options.
View Article and Find Full Text PDF

 The rhesus factor D (RhD)-negative patients who give birth to an RhD-positive newborn or who are otherwise exposed to RhD-positive red blood cells are at risk of developing anti-D antibodies. These antibodies may cause hemolytic disease of the fetus and newborn (HDFN). During pregnancy, prevention of alloimmunization is completed with a Rho(D) immune globulin (RhIg).

View Article and Find Full Text PDF

Preoperative Autologous Blood Donation for Rh-Negative Pregnant Women Undergoing Cesarean Sections.

J Clin Med Res

August 2024

School of Allied Health Sciences, and Hematology and Transfusion Science Research Center, Walailak University, Nakhon Si Thammarat, Thailand.

Background: Cesarean sections (C-section) often require blood transfusions in cases of severe bleeding, particularly challenging in Rh-negative pregnancies due to the scarcity of Rh-negative donors, with only approximately 0.3% of the population in Thailand. Autologous blood donation, where individuals donate their own blood before surgery, offers a promising solution.

View Article and Find Full Text PDF
Article Synopsis
  • Several European countries successfully integrated this method into their routine prenatal care, while it has recently been adopted by two U.S. companies using next-gen sequencing technology.
  • With a current shortage of RhoGAM, there’s a push to use these reliable DNA assays in the U.S. to optimize the use of Rhesus immune globulin for RhD-negative pregnant women.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!